The purpose of this study was to analyze distortion product otoacoustic emission (DPOAE) level and signal to noise ratio in a group of infants from birth to 4 months of age to optimize prediction of hearing status. DPOAEs from infants with normal hearing (NH) and hearing loss (HL) were used to predict the presence of conductive HL (CHL), sensorineural HL (SNHL), and mixed HL (MHL). Wideband ambient absorbance was also measured and compared among the HL types.
INTRODUCTION
Distortion product otoacoustic emissions (DPOAEs) are a common screening and diagnostic test used to assist in the identification and diagnosis of hearing impairment in young infants referred from newborn screening. Thus far, clinical test performance for diagnostic DPOAEs specific to the infant population has yet to be established. Many clinicians use normative DPOAE values obtained from a group of individuals primarily comprised adults for pediatric interpretation (age range: 1.3-96.5 years; Gorga et al. 1997) . However, previous studies have reported that DPOAE responses are age dependent and that there are significant differences in DPOAE level and noise level between infants and adults (Lafreniere et al. 1991; Bonfils et al. 1992; Lasky et al. 1992; Smurzynski et al. 1993; Brown et al. 1994; Bergman et al. 1995; Prieve et al. 1997b; Lasky 1998; Gorga et al. 2000a ). These differences are primarily due to developmental changes that occur in the outer and middle ear (Keefe et al. 1993; Abdala & Keefe 2006; Keefe & Abdala 2007; Hunter et al. 2016) .
With the goal of identification of hearing loss (HL) before 3 months of age and intervention by 6 months of age (JCIH 2007) , optimal clinical interpretation of DPOAE responses in infants is of critical importance. As explained later, it is important to consider both the DPOAE level and signal to noise ratio (SNR) to assess the reliability of the response (SNR > 0), whether a high DPOAE level is due to large amounts of noise in the response or a robust signal generated within a healthy cochlea. Establishing DPOAE level and SNR cutoff values would allow more accurate and efficient diagnosis of HL in the pediatric population.
DPOAE level and SNR cutoff values that accurately predict the presence of HL have not yet been defined in newborns and infants. Gorga et al. (1997) recommended that based on the DPOAE amplitude (i.e., the DPOAE level in the terminology of the present article), DPOAE responses can be placed into three categories including a normal range, abnormal range, or borderline range. The normal range includes DPOAE levels that are greater than the 90th or 95th percentile obtained from individuals with HL, the abnormal range includes DPOAE levels that are less than the 5th or 10th percentile obtained from individuals with normal hearing (NH), and the borderline range includes values that fall in between the normal and abnormal range. A major issue associated with using adult normative data for pediatric DPOAE interpretation is the potential for misdiagnosis. Because DPOAE levels have been reported to be more robust in infants than adults (Lafreniere et al. 1991; Bonfils et al. 1992; Smurzynski et al. 1993; Gorga et al. 2000a Gorga et al. , 2000b , clinicians might incorrectly infer that an infant has normal DPOAE amplitude and therefore NH when in fact their DPOAE amplitude is reduced and may be indicative of HL. Moreover, DPOAE noise levels are larger in infants than adults, which can thereby reduce the SNR in infants.
Audiologic Guidelines for the Assessment of Hearing in Infants and Young Children (American Academy of Audiology 2012) state that DPOAE measurements in infants should include target stimulus levels of L1 = 65 dB SPL and L2 = 50 or 55 dB SPL at 6 to 8 frequencies restricted to F 2 frequencies of 2 kHz and above due to high levels of noise in the low frequencies ). The guidelines further specify that DPOAE responses should be considered present and normal when the SNR is >3 to 6 dB at the majority of F 2 frequencies tested (Lonsbury-Martin & Martin 1990; Avan & Bonfils 1993; Moulin et al. 1994; Smurzynski 1994) , and the DPOAE level falls within age-appropriate normative ranges for NH infants and children (Prieve et al. 1997b; Gorga et al. 2000b; Abdala et al. 2008) . Prieve et al. (1997b) reported DPOAE input-output functions using primary levels ranging from 40 to 65 dB SPL with L 1 > L 2 by 15 dB at F 2 frequencies of 1 to 6 kHz in infants (<1 year, N = 28), toddlers (N = 28), children (N = 105), and young adults (N = 35). Gorga et al. (2000b) reported mean DPOAE level and SNRs with primary levels of 65/50 dB SPL at F 2 frequencies ranging from 1 to 4 kHz from 2348 well babies without risk factors, 353 well babies with at least one risk factor, and 4478 neonatal intensive care unit (NICU) graduates shortly after birth. Abdala et al. (2008) measured DP-grams, defined as "DPOAE level plotted as a function of F 2 frequency," using primary tones of 65/55 dB SPL at F 2 frequencies ranging from 1.5 to 8 kHz in 20 infants shortly after birth, or between 37 and 40 weeks gestational age if they were preterm, and again at 3, 4, 5, and 6 months of age. While all these normative studies used an F 2 /F 1 ratio of 1.22 and the recommended stimulus levels (65/55 or 65/50 dB SPL), they varied in terms of the frequency range measured. Even though it is recommended that DPOAE F 2 frequencies should be limited to 2 kHz and above, Gorga et al. only measured up to 4 kHz and Prieve et al. (1997b) measured up to 6 kHz. While Abdala et al. (2008) measured up to 9 kHz, results were obtained from a small number of infants (N = 20) .
In addition, these infant DPOAE studies had varying approaches to incorporating information on middle ear function and on determining whether the hearing thresholds were within the NH range. Prieve et al. (1997b) recorded 0.226 kHz tympanograms, which cannot be used for neonates to reliably differentiate normal ears and those with middle ear fluid (Paradise et al. 1976; Marchant et al. 1986 ). Prieve et al. assessed NH based on a sound field visual reinforcement audiometry (VRA) test. However, due to the difficult nature of testing young children, reliable results were only obtained in 10% of children less than 2 years of age. Gorga et al. (2000b) reported DPOAE measurements in ears in a newborn hearing screening population for which a subset of ears were further tested on the same test date using energy reflectance measurements of middle ear function (Keefe et al. 2000) . Rather than energy reflectance, the present study considers absorbance, which is defined as the ratio of energy absorbed by the middle ear and ear canal to the incident acoustic energy (Liu et al. 2008; Keefe et al. 2015) . Combined analyses of these DPOAE and absorbance data in newborns showed that middle ear dysfunction identified using an absorbance test partially explained the inability to record a detectable DPOAE in some ears (Keefe et al. 2003b ). The combination of DPOAE and absorbance data in newborns improved the ability to predict hearing status based on a VRA exam at 8 to 12 months corrected age (Keefe et al. 2003a ). The reliance on VRA testing many months later implies that hearing status was unknown at the time of the DPOAE data collection. The scope of Abdala et al. (2008) did not include a measure of middle ear function and assessed NH based on infants passing a clickevoked auditory brainstem response (ABR) screen at 35 dB nHL. Other issues associated with the aforementioned normative studies are that some had a small sample size (Abdala et al. 2008) , focused on preterm/term newborns Abdala et al. 2008) , or combined infants across birth to 1 year (Prieve et al. 1997a) , a time during which many developmental changes occur in ear-canal and middle ear function.
No previous study in infants has reported the ability to classify the type of HL, if present within the first 3 months after birth, based on the DPOAE test and any other test data. It is clinically relevant to determine whether a given HL in an infant is purely sensorineural, purely conductive, or a mixture of sensorineural and conductive. The present study used diagnostic tone burst ABR testing at the same 1-month age at which DPOAE and absorbance data were measured, followed by VRA testing at 9 to 12 months. The ABR test protocol was designed to provide both air and bone conduction thresholds based on Elsayed et al. (2015) . This enabled an assessment of hearing status during this period of follow-up newborn hearing screening testing. The combination of air and bone conduction data enabled the assignment of infant test data into an NH group and in several HL groups including conductive HL (CHL), mixed HL (MHL), and sensorineural HL (SNHL). The major goal of the present study was to evaluate the test performance of DPOAE level and SNR in classifying ears as NH or having an HL (CHL, MHL, or SNHL), and in classifying ears as NH or having pure or mixed SNHL (SNHL or MHL). A secondary goal was to evaluate the ability of an ambient absorbance test to classify ears as NH or having a conductive component to the HL (CHL or MHL). The potential advantage of using both DPOAE and absorbance tests is that a DPOAE test is sensitive to outer hair cell dysfunction leading to an SNHL or MHL, while absorbance is sensitive to middle ear dysfunction leading to a CHL or MHL. A comparison of absorbance tests at tympanometric peak pressure and at ambient pressure was outside the scope of this study.
MATERIALS AND METHODS

Subject Enrollment and Demographics
This study was part of a longitudinal, prospective multiyear project to evaluate the use of a wideband acoustic immittance test battery in conjunction with DPOAE, ABR, and VRA testing to identify middle ear, cochlear, and neural HL in infants and children. Infants were enrolled from the well-baby nursery and NICU after they completed the Universal Newborn Hearing Screening (UNHS) at the birth hospital. In the well-baby nursery, the UNHS was a two-stage protocol that consisted of transient evoked otoacoustic emissions (TEOAEs, clicks at 80 dB SPL) and automated ABR (clicks at 35 dB nHL) if the infant did not pass the TEOAEs in either ear. In the NICU, ABR testing was combined with TEOAE or DPOAE testing as recommended by the Joint Committee on Infant Hearing for infants at higher risk of neurological problems (JCIH 2007) . Screening was completed with the Natus Echo-Screen (Planegg, Germany), and due to proprietary technology, specific pass/refer criteria are not available. Infants participated in up to four study visits from birth to 15 months of age including a visit 1 (birth-4 months.), visit 2 (4-7 months.), visit 3 (7-11 months.), and visit 4 (11-15 months.). The focus of the present study was data collected at visit 1 along with VRA data from visits 3 and 4 to confirm hearing status.
A total of 502 infants (975 ears) were enrolled in the study. However, ears were excluded due to lack of DPOAE data (N = 18), missing ABR data (N = 17), Auditory Neuropathy Spectrum Disorder diagnosis (N = 2), or the age at test was greater than the range for visit 1 (birth to 4.2 months of age; N = 5). This resulted in 844 ears with NH and 89 with HL. An additional 473 ears were excluded as they did not meet the NH inclusion criteria including 115 ears that did not pass twostage UNHS, 343 ears that passed the UNHS, but had inconclusive diagnostic ABR (N = 15), inconclusive VRA (N = 53), elevated VRA results (N = 77), or VRA visit was not completed (N = 213). Four hearing impaired ears were excluded due to missing VRA data. Therefore, a total of 456 infant ears (371 NH and 85 HL) were included in the analysis.
Demographic information for all infants who participated in the present study at visit 1 and were included in the analyses is displayed in Table 1 . A total of 279 infants (149 males and 130 females) and 456 ears were included in this study. Approximately two-thirds of the study participants classified their race as Caucasian, one-third as African American, and the remaining classified as other. The majority of the participants identified their ethnicity as non-Hispanic (97%). Approximately one-third of the infants had at least one risk factor for HL, with NICU stay >5 days, hyperbilirubinemia, and ototoxic medications recorded as the most common risk factors in the medical record.
The diagnosis of hearing status was based on the infant's "overall clinical diagnosis" which considered ABR thresholds and wideband tympanometry from visit 1 along with VRA thresholds obtained at visits 3 and 4 to confirm the presence/ type of HL. In some cases, ABR and VRA thresholds did not agree. The most common cases (18 ears) were elevated ABR thresholds at visit 1 and abnormal wideband tympanometry (low admittance or wide width) with NH at visits 3 and 4; thus, clinical diagnosis was classified as CHL at visit 1. The overall clinical diagnosis was used for the multifrequency analyses. The ABR and VRA test protocol later provides specific information on how HL was diagnosed based on air and bone conduction thresholds for each on the aforementioned tests.
All infants with NH passed the UNHS and had NH verified with both ABR and VRA. Of the 85 ears diagnosed with HL at visit 1, 52 passed the UNHS and all ears had their hearing status verified with VRA. Included in the HL group were 6 infants with craniofacial anomalies, including cleft palate, Pierre Robin, Branchio-Oto-Renal Syndrome, Down syndrome, macrocephaly, and macrocrania.
The majority of the ears with HL were diagnosed with CHL (N = 67), with smaller numbers of SNHL (N = 10) and MHL (N = 8). The mean (and range) of the tone burst ABR thresholds at each test frequency from ears with HL were as follows: 56 dB nHL (40-90 dB nHL) at 0.5 kHz, 49 dB nHL (35-90 dB nHL) at 1 kHz, 52 dB nHL (40-90 dB nHL) at 2 kHz, and 57 dB nHL (40-90 dB nHL) at 4 kHz. For infants diagnosed with CHL, the mean (and range) of the tone burst ABR thresholds at each test frequency from ears with HL was as follows: 51 dB nHL (40-60 dB nHL) at 0.5 kHz, 45 dB nHL (35-70 dB nHL) at 1 kHz, 46 dB nHL (40-50 dB nHL) at 2 kHz, and 47 dB nHL (40-60 dB nHL) at 4 kHz.
Test Protocol
The study was approved by the Institutional Review Board of Cincinnati Children's Hospital Medical Center and Good Samarian Hospital. Informed consent was obtained from the parent(s) of all infants before enrollment. At each visit, otoscopy, DPOAE, and wideband absorbance tests were completed with diagnostic tone burst ABR testing completed at visit 1 and VRA testing completed at visits 3 and 4. All tests were performed within a double-walled sound booth.
DPOAE testing was completed with the Vivosonic Integrity system (Version 5.2, Toronto, ON, Canada) with an ILO P40-UG probe. Recording parameters included primary tone stimulus levels of 65 dB SPL (L1) and 55 dB SPL (L2) with an F 2 /F 1 frequency ratio of 1.22 (Gaskill & Brown 1990; Abdala 1996; Stover et al. 1996) . Before recording DPOAEs in each ear, in situ calibration was performed using a 1 kHz tone. Next, DPOAE level and noise floor were measured at the DPOAE frequency of 2F 1 −F 2 in descending order at seven F 2 frequencies (8, 5.5, 4, 3, 2, 1.5, and 1 kHz). The SNR was calculated by subtracting the DPOAE noise level from the DPOAE level at each F 2 test frequency. This means that the calculated SNR was sometimes negative in some ears, and this convention was used in the analyzed results. As a practical matter, such SNRs might be interpreted as if the SNR was 0 dB, because a DPOAE ON, Canada) . Infants were tested after bottle or breast feeding, while the infant was asleep or awake but resting quietly in their caregiver's arms or in an infant bouncer. Stimuli were presented at a rate of 37.1 per second through insert earphones (Etymotic Research ER-3A, Elk Grove Village, IL) and a standard hand-held Radioear B-71 bone vibrator (Radioear Corp, New Eagle, PA). Contralateral broadband masking noise was presented at a level of 10 dB above the test stimulus. Masking was always applied for bone conduction testing; however, for air conduction, it was only applied when there was a 50 dB or greater asymmetry in air conduction thresholds between ears. Reference values at 0 dB nHL in peak-to-peak equivalent SPL at 0.5, 1, 2, and 4 kHz were 25, 26, 31, and 35 dB, respectively, for ER-3A insert earphones and 67, 54, 49, 41 dB peak-to-peak equivalent in reference to 1 micro-Newton Root Mean Square for the B-71 bone vibrator per Vivosonic documentation. At a minimum, air conduction tone burst thresholds were measured at 1 and 4 kHz in all infants and also at 0.5 and 2 kHz if time permitted (based on the behavioral status of the infant and parent). Likewise, bone conduction ABR thresholds were measured at 1 and 4 kHz if possible and then at 0.5 and 2 kHz if time permitted. For multifrequency analyses, normal ABR air conduction thresholds were defined as 40 dB nHL or better at 500 Hz, 30 dB nHL or better at 1 and 2 kHz, and 20 dB nHL or better at 4 kHz. ABR bone conduction thresholds were considered normal if they were ≤30 dB nHL. A significant air-bone gap (air conduction level minus the bone conduction level at the same test frequency) was defined as air-bone gaps of ≥20 dB at 0.5 and 1 kHz and ≥10 dB at 2 and 4 kHz. The criteria used to define normal and abnormal ABR thresholds were based on values reported by Elsayed et al. (2015) and Vander Werff et al. (2009) .
VRA testing was completed using an Intelligent Hearing Systems Smart VRA device with insert earphones (Etymotic Research ER-3A, Elk Grove Village, IL) and a Radioear B-71 bone vibrator (Radioear Corp, New Eagle, PA). The VRA test protocol was modeled on Widen et al. (2000) and was completed using two examiners with catch trials to assess false-positive responses. A speech awareness threshold using recorded speech syllables (da da or ba ba) and air and bone conduction tone burst thresholds were measured from 0.5 to 4 kHz. At a minimum, thresholds were measured at 1 and 4 kHz in all ears. Thresholds at 0.5 and 2 kHz were also measured if time permitted and the child was attentive. Bone conduction VRA thresholds were measured at 1 and 4 kHz if possible and then at 0.5 and 2 kHz if time permitted. For multifrequency analyses, the VRA criteria for NH was a minimum response level of 25 dB HL or better for all speech syllables and warble tones between 1 and 4 kHz, and 30 dB HL or better at 500 Hz. An air-bone gap was considered significant if it exceeded 10 dB for the speech awareness threshold and warble tones between 1 and 4 kHz, and if it exceeded 20 dB at 0.5 kHz.
Wideband tympanometry absorbance data were acquired using custom research software on a personal computer with a Titan probe and modified AT-235 tympanometry hardware (Interacoustics AT-235 and Titan probe, Middlefart, Denmark) from 0.25 to 8 kHz. A detailed description of test procedures along with individual results from infant ears is described in Keefe et al. (2015) . Normal tympanometric ambient absorbance values obtained from the same group of NH infants in the current study as reported by Hunter et al. 2016 were used to determine normal middle ear function.
The ABR and VRA criteria used to diagnose NH and CHL, SNHL, and MHL are as follows. NH was defined as normal air and bone conduction thresholds without a significant air-bone gap at all test frequencies. The definition of CHL was abnormal air conduction and normal bone conduction combined with a significant air-bone gap at the same frequency. The definition of SNHL was an abnormal air and bone conduction threshold at the same frequency, without a significant air-bone gap. The definition of MHL was an abnormal air and bone conduction for the same frequency, combined with a significant air-bone gap.
All infants included in the study with NH or who were diagnosed with CHL, SNHL, or MHL via ABR at visit 1 had their hearing status verified with VRA at visits 3 and 4 as participation in the present study (N = 422 ears) or through a routine clinical audiology (nonstudy) visit (N = 34 ears) that occurred around 9 months of age or later. Of the 422 infant ears that had their hearing status verified through a study visit, ear-specific VRA thresholds were obtained in 98% of infants with NH and 96% of infants diagnosed with HL. Reliability of the VRA test results was classified as fair (7%) and good (93%) for NH infants and fair (14%) and good (86%) for infants with HL. Poor VRA reliability was reported for some NH infants, and such infants were excluded from analyses as not meeting the NH inclusion criteria (e.g., pass two-stage UNHS and NH verified with both ABR and VRA). In about 80% of cases with CHL diagnosed by ABR, hearing was determined to be normal upon later testing by the VRA test at visit 3 or 4 and thus was consistent with a temporary CHL at visit 1. Approximately 20% of cases required insertion of pressure-equalizing tubes to resolve a CHL.
Statistical Analyses
DPOAE Level and SNR • Separate one-way analysis of variance (ANOVA) tests were conducted for each DPOAE F 2 test frequency (1, 1.5, 2, 3, 4, 5.5, and 8 kHz) to determine if the mean DPOAE levels and SNRs were different based on hearing status. ABR thresholds and the infants' overall clinical diagnosis were used to classify infants into an NH group and HL group (CHL, SNHL, MHL combined). Data were analyzed with SigmaPlot Version 13.0 (Systat Software, San Jose, CA) with the significance level set to p < 0.05. Ambient Absorbance • A mixed model ANOVA was conducted to examine differences in ambient absorbance across 11 ½ octave frequencies (0.25, 0.35, 0.5, 0.7, 1, 1.4, 2, 3, 4, 6, and 8 kHz) between the following three groups of infants: NH, SNHL, and HL with a conductive component (CHL and MHL combined). Significant group differences were further analyzed with post hoc pairwise comparisons with studentized maximum modulus adjustments. Data were analyzed with SAS statistical software, version 9.3 (SAS Institute, Cary, NC) with the significance level set to p < 0.05. Receiver Operator Characteristic Curve Analyses • Receiver operating characteristic (ROC) curves were constructed to evaluate the diagnostic utility of DPOAEs to separate ears with NH and abnormal hearing. Two levels of ROC analyses were completed: (1) ROC curves were constructed for each DPOAE F 2 frequency for both DPOAE level and SNR to establish symmetry cutoff values for frequency-specific interpretation of DPOAEs (i.e., single-frequency ROC analyses). (2) Next, several multifrequency ROC analyses were completed to determine the optimal number of frequencies required to pass to classify the ear as NH and to determine which DPOAE F 2 test frequencies provide best test performance. For the single-frequency ROC analyses, an ABR cutoff value of 30 dB nHL was chosen to represent NH based on its use in a study in predominantly adult ears by Gorga et al. (1997) . This study reported that ROC test performance of DPOAEs in a predominantly adult group of test ears was best when NH levels were defined as audiometric thresholds from 20 to 30 dB HL, with test performance declining as the NH criteria became more lax or stringent. Therefore, for single-frequency ROC analysis in the present study, NH was defined as ABR air conduction thresholds ≤30 dB nHL for all test frequencies. ROC curves were not completed for the DPOAE data collected at the 9 to 12 months of age due to a limited number of infants that displayed HL with VRA at visit 3 (N = 14) or visit 4 (N = 3). This is due to the fact that the majority of infants with CHL at visit 1 no longer had a conductive component at their 9-or 12-month visit. For the multifrequency ROC analysis, the infant's hearing status was based on their overall clinical diagnosis which considered ABR thresholds and wideband tympanometry from visit 1 along with VRA thresholds obtained at visits 3 and 4 to confirm the presence/type of HL. Single-Frequency DPOAE Signal Level and SNR ROC Analyses • ROC curves were constructed for each DPOAE F 2 frequency and only included infants where both the DPOAE and corresponding ABR thresholds were available. Therefore, the total number of ears included in the ROC analysis varied by frequency. Two prediction variables, DPOAE level and SNR, were separately analyzed at each test frequency by construction of a pair of ROC curves. Each ROC curve quantified the ability of its prediction variable to classify ears as NH or HL (any of CHL, MHL, or SNHL). Two summary indices of each ROC curve were calculated: the nonparametric area under the ROC curve (AUC) and the point of symmetry (SYM) on the curve at which the sensitivity and specificity were equal (Pepe 2003) , or most nearly equal. The AUC was used as the overall measure of test performance for each predictor variable. Symmetry cutoff values for DPOAE level and SNR were defined as the SYM of their respective ROC curves, which fixed the operating point of the test to have both a relatively high specificity and relatively high sensitivity. ROC analyses were performed with SigmaPlot Version 13.0 (Systat Software, San Jose, CA). Multifrequency DPOAE Signal Level and SNR ROC Analyses • The above ROC curve analyses are generally similar to those used in previous studies to evaluate the accuracy of DPOAE data to classify ears as normal or abnormal at a single frequency. One limitation of these analyses is that two AUCs are calculated at each DPOAE F 2 frequency (DPOAE level and SNR), whereas it is clinically relevant to evaluate each test ear as normal or abnormal. The first step in addressing this limitation is to use both the DPOAE level and SNR symmetry cutoff values obtained in the single-frequency ROC analysis to classify each F 2 test frequency as normal or abnormal. The present study defined a single DPOAE F 2 test frequency as a pass if it was a pass according to both of the level and SNR cutoffs and was defined as a nonpass DPOAE otherwise. This resulted in a pass ear having a sufficiently large DPOAE level and a sufficiently large SNR. The SNR cutoff value was not determined in terms of any given a priori choice of value (such as 3 or 6 dB, as described in the Introduction), and similarly for the DPOAE level cutoff. Instead, the DPOAE level and SNR symmetry cutoff values (i.e., the SYM of the ROC curves) were obtained from the single-frequency ROC curves. This approach differs from Norton et al. (2000b) who evaluated DPOAE test performance in neonates using AUCs based on SNR only. A second step to address this limitation of single-frequency ROC curves was to combine the DPOAE test results across frequency to provide a single classification of each test ear as normal or abnormal (i.e., multifrequency analyses). Such a single classification of hearing status is clinically relevant.
Therefore, multifrequency analyses were completed to determine the ability of the DPOAE level and SNR symmetry cutoff values combined across frequency to correctly classify ears with various types of HL according to the infant's overall clinical diagnosis. The single-frequency ROC results described later showed that DPOAEs at F 2 frequencies of 1 and 1.5 kHz were inaccurate at classifying ears as NH or HL. Thus, the multifrequency analyses were restricted to F 2 frequencies of 2 kHz and higher. This low-frequency restriction, that is, excluding F 2 test frequencies below 2 kHz, is similar to that used in neonates Norton et al. (2000a) . Another difference is that the maximum F 2 test frequency of 8 kHz in the present study was higher than the 4 kHz frequency used in the neonatal study.
A total of 4 multifrequency analyses were completed. A "5 Frequency Analysis" included DPOAE data at five F 2 frequencies (2, 3, 4, 5.5, and 8 kHz), two versions of a "4 Frequency Analysis" were evaluated that included DPOAE data at four F 2 frequencies across (3, 4, 5.5, and 8 kHz) and (2, 3, 4, and 5.5 kHz), and a "3 Frequency Analysis" included DPOAE data at three F 2 frequencies (2, 3, and 4 kHz). The rationale for analyzing these four conditions was that the AUCs were lower at 2 kHz than at all higher frequencies (see Results), so it was of interest to compare multifrequency analyses in which the DPOAE predictors at 2 kHz were either included or excluded. In addition, most previous studies stopped at F 2 frequencies of 4 kHz, and therefore, we wanted to evaluate whether test performance improved by including DPOAE data at 5.5 and 8 kHz. These multifrequency analyses were completed for two dichotomous groups of ears: NH or HL (CHL, SNHL, and MHL subgroups) and NH or a sensorineural component of HL (SNHL and MHL). The inputs to the multifrequency analyses included the pass/refer status based on both the DPOAE level and SNR, which were calculated using the cutoff at the SYM of their respective ROC curve at each frequency.
Previous research studies have combined DPOAE results across multiple F 2 frequencies by defining a DPOAE pass based on passing at a certain number of F 2 frequencies or better. This approach was evaluated in the present study. For example, in the 5 Frequency Analysis, the sensitivity and specificity were evaluated at each condition requiring a pass on both DPOAE level and SNR at 1, 2, 3, 4, or all 5 frequencies. A novel aspect of the present study was to embed this type of multifrequency analysis in a second level of ROC curve analysis. For example, in the 4 Frequency Analysis (3 and 5 Frequency Analysis proceeded along similar lines), a new ROC curve was constructed by classifying a test ear as DPOAE pass (i.e., NH) if the ear had a DPOAE pass at 0 or more, 1 or more, 2 or more, 3 or more, or all 4 test frequencies. The 0-or-more pass condition classified all ears as passing the DPOAE (specificity of 1, sensitivity of 0), and a fifth endpoint was added to the ROC curve after the all-4 pass condition that represented that no ears passed the DPOAE (specificity of 0, sensitivity of 1). The nonparametric AUC was calculated using Excel, and the optimum predictor was identified as the multifrequency test that was closest to the SYM value of the ROC curve. This optimized the final DPOAE test performance using a criterion with relatively high specificity and high sensitivity. In summary, DPOAE test performance was evaluated for two dichotomous groups of ears: NH or HL (CHL, SNHL, and MHL subgroups) and NH or a sensorineural component of HL (SNHL and MHL). As described later, the number of pure SNHL ears (N = 10) was insufficient to allow an evaluation of test performance for classifying ears as NH or SNHL.
RESULTS
Although this was part of a longitudinal study, only infant data collected at visit 1 (ambient absorbance, DPOAEs, ABR) are discussed with VRA data collected at visits 3 and 4 used to confirm the presence of HL. The companion paper (Hunter et al., Reference Note 1) describes longitudinal results on DPOAEs in infants with NH from birth to 15 months of age. Figure 1 displays the individual DPOAE level and SNR values from ears with HL (CHL, SNHL, MHL) plotted over normative data obtained from 1-month-old infants with NH that was presented in the companion paper (Hunter et al., Reference Note 1). The light gray shaded area represents the 10th to 90th percentiles, the dark gray shaded area represents the 20th to 80th percentiles, and the black line represents the median or 50th percentile from NH infants. Data points were jittered by frequency for easier visualization. It is important to note that although the 5th to 95th percentiles are commonly used to define normal ranges, in infants the 5th percentile is mostly below the noise floor. Therefore, we evaluated more stringent criteria for SNR and DPOAE level.
DPOAE Level and SNR
From 1 to 2 kHz, DPOAE level and SNR values from infants with HL substantially overlapped the NH distribution. At 3 kHz and above, most of the DPOAE level and SNR values from infants with HL fell below the 50th percentile with the majority of the data points at or below the 10th to 20th percentiles from the NH distribution. In addition, the range of DPOAE level and SNR values from individuals with different types of HL (CHL, SNHL, MHL) were similar. Some extreme values are marked in Figure 1 and are discussed later (See Case Studies). Figure 2 displays the mean DPOAE level (top panel) and SNR (bottom panel) for infants with NH, CHL, and SNHL/ MHL combined. Brackets represent the 95% confidence intervals of the mean and were jittered around the frequency axis for visualization purposes. Infants with NH had the largest mean DPOAE level and SNR at all frequencies with the exception of 1 kHz, at which the confidence intervals substantially overlapped between NH, CHL, and SNHL/MHL groups. The DPOAE level and SNR confidence intervals from infants with CHL compared with those with SNHL/MHL, overlapped at all F 2 test frequencies with the exception of DPOAE SNR at 5.5 kHz. The confidence intervals for infants with CHL were separated from infants with NH from 2 to 8 kHz for DPOAE level and from 1.5 to 8 kHz for DPOAE SNR. For infants with SNHL/MHL, the confidence intervals were clearly separated from infants with NH from 1.5 to 2 kHz and 4 to 8 kHz for DPOAE level and from 1.5 to 8 kHz for DPOAE SNR. In general, the greatest overlap in confidence intervals between infants with NH and abnormal hearing occurred in the lower frequencies, with more separation as F 2 frequency increased.
One-way ANOVAs were conducted to determine if there were statistically significant mean differences in DPOAE level and SNR between infants with NH and HL. Due to the small number of infants with HL and the fact that the distributions from infants with CHL, SNHL, and MHL were overlapping, data from all infants with HL were combined to form a single HL group (CHL, SNHL, MHL combined). DPOAE level and SNR, with the exception of SNR data at 1 and 1.5 kHz, were not normally distributed, as assessed by Shapiro-Wilk test (p < 0.05), and therefore, a Kruskal-Wallis one-way ANOVA on Ranks was performed. Results indicated statistically significant differences in the mean DPOAE level and SNR between the NH and HL groups (p < 0.001) at all DPOAE F 2 test frequencies from 1.5 to 8 kHz. Fig. 1 . Individual DPOAE level and SNR values for infants with conductive, sensorineural, and mixed hearing loss plotted over the 1-month normative data from companion paper (Hunter et al., Reference Note 1). The light shaded area represents the 10th to the 90th percentiles and the dark shaded area represents the 20th to 80th percentiles. Several data points that were well outside of the 90th percentile are identified with participant numbers and will be discussed in the text. CHL indicates conductive hearing loss; DPOAE, distortion product otoacoustic emission; MHL, mixed hearing loss; SNHL, sensorineural hearing loss; SNR, signal to noise ratio. Figure 3 displays the mean ambient absorbance for NH, CHL, SNHL, and MHL groups as a function of test frequency. Brackets represent the 95% confidence intervals, which are slightly offset horizontally for visualization purposes. The NH and SNHL groups had the highest mean absorbance across all frequencies from 0.25 to 8 kHz. The MHL group had the lowest mean ambient absorbance values at all frequencies with the exception of 3 to 4 kHz which displayed a minimal difference in mean ambient absorbance values compared with the CHL group.
Ambient Absorbance
A mixed model ANOVA was conducted to examine differences in mean ambient absorbance among the following three groups of infants: NH, SNHL, and HL with a conductive component (CHL and MHL combined) . Results displayed a significant main effect of group for ambient absorbance test frequencies from 1 to 8 kHz. Post hoc pairwise comparisons (see Table 2 ) revealed a significant difference in mean ambient absorbance values between the NH and CHL/MHL groups at all frequencies from 1 to 8 kHz (p < 0.001) with larger mean absorbance in NH ears, but no difference between NH and SNHL ears at any frequency (p > 0.05). A significant difference was also found between the SNHL and CHL/MHL group at 8 kHz, likely due to the small number of SNHL ears. There were no significant differences in the mean ambient absorbance between any of the groups at frequencies below 1 kHz.
Single-Frequency ROC Curves
ROC curves were constructed for each DPOAE F 2 frequency to evaluate the extent to which ears with NH and HL (CHL, SNHL, MHL combined) could be distinguished based on DPOAE level and SNR value. The corresponding AUC values and symmetry cutoff values for DPOAE level and SNR are displayed in Table 3 . The overall test performance was best at 8 kHz and progressively worsened as the test frequency decreased. The highest AUC values were found for frequencies between 3 and 8 kHz. Performance at 1 kHz for both DPOAE level and SNR was around chance, and intermediate performance was seen at 1.5 and 2 kHz. At all frequencies, test performance was better, or at least the same, for DPOAE SNR compared with DPOAE level. DPOAE levels and SNR values greater than or equal to the cutoff values in Table 3 would be considered consistent with NH or a slight/mild HL and those below these values would indicate abnormal function. In particular, the cutoffs for SNR varied with frequency between 2 and 8 kHz over a range from 4.9 to 12.7 dB. Thus, the definitions of pass and nonpass based on the SYM of the ROC curve differed across frequency and indicated that using a fixed criterion level of SNR (e.g., 3 or 6 dB) was not adequate.
Multifrequency DPOAE Level and SNR Analysis
As described in the Materials and Methods section, the multifrequency analyses combined DPOAE data across the frequency range into a single predictor of hearing status for each test ear. Due to poorer performance at 1 and 1.5 kHz based on AUC values (see Table 3 ), these frequencies were not included in the multifrequency analyses. These analyses determined (1) the ability of the cutoff values based on the SYM of the ROC curve for each of the DPOAE level and SNR variables to correctly classify ears with various types of HL, and (2) whether DPOAE data at 2 kHz are effective for clinical interpretation due to intermediate performance based on AUC (see Table 3 ), compared with data at higher frequencies. Results from the multifrequency analyses were compared with the infant's overall clinical diagnosis, and the corresponding sensitivity and specificity were calculated for NH ears compared with ears in the following two groupings of HL: (1) CHL, SNHL, MHL combined as in the HL group defined earlier, and (2) SNHL/ MHL combined. Table 4 displays the sensitivity, specificity, and AUC values for the multifrequency analyses. These include a "5 Frequency Analysis (2-8 kHz)," two "4 Frequency Analyses (2-5.5 kHz) and (3-8 kHz)," and a "3 Frequency Analysis (2-4 kHz)," as functions of the number of test frequencies at which a DPOAE pass was required. The sensitivity and specificity in each analysis were based on the symmetry cutoff values reported in Table 3 for DPOAE level and SNR. In general, as the number of frequencies required for a passing result increased, the overall sensitivity increased and the specificity decreased. In addition, sensitivity increased when ears with a CHL were excluded as in the combined SNHL and MHL group. For example, for the 5 Frequency Analysis of DPOAE test data, the AUC was 0.82 to classify ears as NH or HL (including all CHL, SNHL, and MHL ears), and the AUC increased to 0.96 to classify ears as having a sensorineural component to the HL (i.e., the combined SNHL and MHL group). The AUC results for both 4 Frequency Analyses and the 3 Frequency Analysis of DPOAE test data displayed a similar improvement in test performance by excluding the ears with a pure CHL from the HL group.
As a clinical tool, it is necessary to select a particular multifrequency test and criteria to use for interpretation. Due to the high cost of missing an infant with HL compared with the cost of completing an unnecessary additional test (in the case of an infant with NH being misdiagnosed with HL by DPOAEs), the optimal test was chosen as one that had high sensitivity (ideally close to 100%) and adequate specificity (ideally 80% or higher). It is recommended that either a "5 Frequency" or "4 Frequency (3-8 kHz)" criteria with the majority of test frequencies passing both DPOAE level and SNR be used for interpretation to optimize both sensitivity and specificity.
For the 5 Frequency Analysis, the optimum multifrequency DPOAE test for the combined HL group (CHL, SNHL, MHL) was a pass at 3 of 5 of the F 2 test frequencies, for which the sensitivity was 73% and the specificity was 82%. The optimum multifrequency test for the HL group (SNHL, MHL) with CHL ears excluded was that the single-frequency DPOAE tests were a pass at 3 of 5 of the F 2 test frequencies, for which the sensitivity was 100% and the specificity was 82%. Thus, the sensitivity for the 3 of 5 pass condition was excellent for classifying ears with mild or greater sensorineural or mixed loss, but was lower when ears with a pure CHL were included.
For the "4 Frequency Analysis (3-8 kHz)," the optimum multifrequency DPOAE test for the HL group (CHL, SNHL, MHL) was that the single-frequency DPOAE tests were a pass at 3 of 4 of the F 2 test frequencies, for which the sensitivity and specificity were both 76%. The optimum multifrequency test for the HL group (SNHL, MHL) with CHL ears excluded was that the single-frequency DPOAE tests were a pass at 3 of 4 of the F 2 test frequencies, for which the sensitivity was 100% and the specificity was 76%. Previous studies in predominantly adult ears have also shown that audiometric status is better predicted when multiple DPOAE test frequencies are considered Gorga et al. 1999; Gorga et al. 2005) . However, these studies used multivariate analyses with logistic regressions. The multifrequency analyses in the present study include SYM values from single-frequency analyses that can be entered into the DPOAE acquisition software. In testing a new subject, the clinician would only need to ensure that both DPOAE level and SNR are a pass at 3 of 5, or 3 of 4, test frequencies to classify the DPOAE results as consistent with overall normal OHC function within the test frequency region. If the DPOAE level and SNR do not meet the 3 of 5 or 3 of 4 recommendation, the clinician could infer that DPOAE results are consistent with at least a mild HL in that ear at a minimum of one frequency region.
Normal and Abnormal Distributions of DPOAE Level and SNR in Infants
Figure 4 displays DPOAE level and SNR percentiles obtained from NH and HL infant ears (CHL, SNHL, MHL combined) as a function of F 2 frequency at visit 1. The solid line limiting the upper portion of the gray shaded region represents the 90th percentile obtained from the infants with HL, and the solid line limiting the lower portion of the gray shaded region represents the 10th percentile obtained from NH infants. The gray shaded region represents the area of overlap between the aforementioned percentiles. The 90th and 10th percentiles were selected because the noise distribution for infants is wider and the 5th percentile would result in negative SNRs in the low frequencies. However, alternative percentiles could be selected if desired for clinical application. The dotted line represents the DPOAE level and SNR symmetry cutoff values from Table 3 , which correspond to the respective SYM each of their ROC curves at each frequency. DPOAE level and SNRs that are above the symmetry cutoff values (dotted line) are indicative of normal outer hair cell function, and those plotted below are consistent with abnormal function. In addition, overall DPOAE level can be further categorized as normal as values that are greater than 90th percentile from infants with HL, absent or abnormal if they fall below the 10th percentile from infants with NH, or low if they fall within the gray shaded area of overlap between the normal and impaired distributions. Gorga et al. (1997) reported both the 90th and 95th NH percentiles and the 5th to 10th HL percentiles in their DPOAE study with predominantly adult ears. However, they had a much larger sample size (N = 1267 ears), which resulted in more ears contributing to the 5th and 95th percentiles. In the present study, a higher percentage of infants lacked detectable DPOAEs, so that the 5th percentile was in the range of 0 dB SNR for several frequencies. DPOAE level and SNR percentiles (1st, 5th, 10th, 20th, Median, 80th, 90th, 95th, 99th) for ears with NH are provided in the companion paper (Hunter et al., Reference Note 1), and percentiles for ears with HL are provided as Supplemental Digital Content 1, http://links.lww.com/EANDH/A411. Supplemental Digital Content 2, http://links.lww.com/EANDH/ A412, provides a form that can be used for the clinical interpretation of DPOAEs in infants from birth to 4 months of age.
DISCUSSION
DPOAE Signal and SNR From Infants With HL
The present study demonstrated a general trend that infants with HL displayed reduced DPOAE levels and smaller SNRs compared with infants with NH. However, there was not a complete separation in DPOAE level and SNR values between the two groups, that is, the HL and NH distributions overlapped (Figs. 1, 2) . This overlap was more pronounced in the low to mid frequencies (1-2 kHz) with greater separation obtained at higher test frequencies (3-8 kHz). For example, at 8 kHz, there was a clear separation in mean DPOAE level between infants with NH and CHL and a clear separation in SNR between the NH group and either of the CHL and SNHL/MHL groups. However, for DPOAEs at 1 kHz, the mean levels were 8.9, 8.7, and 11.6 dB SPL, and the mean SNRs were 2.2, 0.9, and 3.3 dB for the NH, CHL, and SNHL/MHL groups, respectively.
Ambient Absorbance
By comparing DPOAE and ambient absorbance data in infants with NH, SNHL, and CHL/MHL, the results indicate that the presence of a conductive component to any HL might be predicted using an absorbance test, once the ear was predicted to have some kind of HL based on the DPOAE test. Therefore, when measuring DPOAEs, it is recommended that wideband absorbance be included in the test battery to determine if there is a conductive component to the HL. Because wideband absorbance contains information about middle ear transmission in the same frequency region as the DPOAE test, it is highly relevant to interpretation of results. Information about the status of the middle ear combined with DPOAE responses would guide clinicians during subsequent audiological testing and help maximize the information obtained during the appointment. For example, if DPOAEs are abnormal and absorbance is low, during ABR testing, the clinician may lower the intensity in smaller step sizes or move to bone conduction testing sooner depending on infant state.
Single-Frequency ROC Curves
Since there was an overlap in the normal and impaired distributions at all F 2 frequencies, it is not possible to select a DPOAE level and SNR cutoff value for which no diagnostic errors would occur. DPOAE fine structure may be partially responsible for the overlap in distributions and the variable correlations between DPOAE level and audiometric thresholds (Heitmann et al. 1996; Talmadge et al. 1999 ). Consistent with adult data, DPOAE test performance in infant ears, as assessed by the AUC value (see Table 3 ), was highly frequency dependent. DPOAEs were more accurate in the mid to high F 2 frequencies (≥3 kHz) with poorer identification at lower F 2 test frequencies (≤2 kHz). Poorer test performance at 1 and 1.5 kHz was associated with reduced SNRs, see Figure 1 , bottom panel (Brown et al. 2000) . Gorga et al. (1997) reported AUC values that ranged from 0.78 to 0.95 for DPOAE level and 0.83 to 0.94 for DPOAE SNR. Their study excluded ears with an air-bone audiometric gap of 10 dB or more. With the exception of 8 kHz, Gorga et al. reported AUC values that ranged from 0.03 to 0.3 higher than the present study. The largest difference was observed at 1 kHz where Gorga et al. reported AUC values of 0.78 and 0.83 for DPOAE level and SNR, respectively, compared with the present results of 0.48 and 0.54. At 8 kHz, Gorga et al. reported a decrease in test performance with AUCs of 0.83 and 0.84 for DPOAE level and SNR, respectively. In contrast, the present study reported the best test performance at 8 kHz with AUC values of 0.91 and 0.94 for DPOAE level and SNR. A major factor in this difference in test performance was age: the youngest subject tested in Gorga et al. was 1.3 years old, while the oldest subject in the present study was 4.1 months of age. Thus, there was no overlap between age groups in these two studies. Other possible factors are that conductive-loss ears were excluded from the Gorga et al. study but were included in the present study, and noise levels were higher in infants than adults, especially at 1 kHz. Acoustic standing wave effects are significant in adult ear canals above 2 kHz, whereas they are small in infant ear canals at all frequencies up to 8 kHz. Thus, the test performance difference at 8 kHz between the adult and infant studies may be due to stimulus level differences between adult and infant ears, which would depend on the details of calibration. DPOAE test performance was very similar for DPOAE level and SNR, although SNR resulted in slightly higher AUC values. Gorga et al. (1997) reported that the AUCs based on SNR data were higher for all test frequencies from 0.75 to 8 kHz with the exception of 1.5 and 4 kHz. The present results were similar, with higher AUCs based on SNR data at all test frequencies from 1 to 8 kHz with the exception of 2 and 5.5 kHz. Poorer performance for DPOAE level was likely due to the influence of ears with small SNRs, which were associated with a DPOAE level dominated by noise. However, any performance advantage for using only SNR was small. This is not surprising because DPOAE level and SNR are not independent. Irrespective of those differences, the present study combined DPOAE data on level and SNR to classify each ear into NH or HL groups. This means that there is no need to choose only one of these test variables.
Multifrequency DPOAE Level and SNR Analyses
Multifrequency analysis rules are recommended to allow clinical interpretation of DPOAE responses, instead of singlefrequency interpretation. The present results support the use of multifrequency criteria, requiring 3 out of 5 frequencies from 2 to 8 kHz or 3 out of 4 frequencies between 3 and 8 kHz to pass both the DPOAE level and SNR using the symmetry cutoff values (see Table 3 ). Excluding 2 kHz from the multifrequency analysis provides a 6% increase in specificity with minimal change in sensitivity. Multifrequency analysis could be combined with reflectance test data to classify ears as having a conductive component to the HL (CHL or MHL). For example, if both the DPOAE level and SNR are a pass at 3 of 5 or 3 of 4 test frequencies, the clinician could report that DPOAEs are consistent with overall normal OHC function within the test frequency region. However, if the DPOAE level and SNR do not meet the 3 of 5 or 3 of 4 recommendation, the clinician could infer that DPOAE results are consistent with at least a mild HL in that ear at a minimum of one frequency region. Furthermore, if absorbance results are normal, the infant would be considered to be at a high risk for a permanent HL.
DPOAEs in Infants Compared With DPOAEs in Adults
Clinically, the 90th percentile from HL and 5th percentile from NH individuals are most commonly used for DPOAE level interpretation (Gorga et al. 1997; Cunningham 2011) . To determine how infant DPOAE levels would be classified compared with the adult norms from Gorga et al. (1997) , individual DPOAE levels from infants diagnosed with HL plotted over the normal, abnormal, and borderline ranges from Gorga et al. in Figure 5 . The borderline range is indicated by the gray shaded area and refers to the area of uncertainty for which the clinician is unable to assign status of normal or loss to the DPOAE response. DPOAE levels plotted above the gray shaded area are in the normal range (>90th percentile from individuals with HL), and DPOAE levels plotted below the gray shaded area are in the abnormal range (<5th percentile from NH individuals).
When using Gorga et al. (1997) norms for infant DPOAE level interpretation, a significant number of DPOAE data points from HL ears would be classified as normal. The percentage of ears misclassified varied as a function of frequency, with the majority of ears misclassified at 4 kHz (65%) and 8 kHz (43%). However, when using Gorga et al. SNR norms, only 4 to 5% of ears were misclassified at 2, 3, and 5.5 kHz and no ears were misclassified at 4 and 8 kHz. This is due to the higher DPOAE noise levels in infants compared with adults that is not offset by an equivalent increase in mean DPOAE levels (Hunter et al, Reference Note 1) . This results in smaller SNRs in infants compared with adults. Our results further confirm that interpretation of infant DPOAEs needs to be conducted with age appropriate norms, particularly for level.
Case Studies
In Figure 1 , several infants with HL had DPOAE levels and SNRs that were at or above the 90th percentile of the NH group. These 3 infants were identified in the figure by numerical values (i.e., 1, 2 and 3) next to their DPOAE level and SNR data points and are discussed as case study 1, 2, and 3, respectively. Case Study 1 • Infant number 1 had several risk factors for HL including hyperbilirubinemia, ototoxic medications, low birth weight (<1500 g), and NICU stay (>5 days). The infant was diagnosed with an MHL via ABR with air conduction thresholds of 60 dB nHL at 1 kHz and 40 dB nHL at 4 kHz. ABR bone conduction thresholds were not able to be obtained; however, ambient absorbance results displayed in Figure 6A show normal to high absorbance from 0.25 to 0.7 and low/abnormal absorbance from 1 to 8 kHz. Figure 6B displays DPOAE level and SNR values from infant number 1 plotted over 1-month normative data (90th percentile from infants with HL to 10th percentile from NH infants) and symmetry cutoff values. Despite the diagnosis of an MHL, infant number 1 displayed high DPOAE levels at most DPOAE F 2 test frequencies with responses well above the symmetry cutoff values; however, DPOAE SNR levels at 4 of 5 test frequencies from 2 to 8 kHz were below the symmetry cutoff values. When DPOAE level and SNR symmetry cutoff criteria were used to determine overall DPOAE status, infant number 1 Fig. 5 . DPOAE levels from infants diagnosed with hearing loss are plotted as a function of F 2 frequency over the normal, abnormal, and borderline ranges from Gorga et al. (1997) . The border line range is indicated by the dark gray shaded area. DPOAE levels plotted above the gray shaded area are in the normal range (>90th percentile from individuals with hearing loss), and DPOAE levels plotted below the gray shaded area are in the abnormal range (<5th percentile from NH individuals). The borderline range is indicated by the gray shaded area and refers to the area of uncertainty for which the clinician is unable to assign status of normal or abnormal to the DPOAE response. CHL indicates conductive hearing loss; DPOAE, distortion product otoacoustic emission; MHL, mixed hearing loss; NH, normal hearing; SNHL, sensorineural hearing loss.
passed the DPOAE level at all test frequencies but failed SNR at all frequencies from 3 to 8 kHz. Therefore, in the multifrequency analysis using both DPOAE level and SNR criteria, DPOAE responses for infant number 1 were correctly identified as abnormal. The MHL was confirmed with VRA air conduction thresholds that ranged from 55 to 75 dB HL with a 30 dB air-bone gap at 1 kHz. The higher noise levels could be due to excessive fussiness during DPOAE measurement. If noise was the issue during testing, the clinician could indicate that the high DPOAE level and thus low SNR were likely due to excessive noise and that repeated DPOAE testing would be recommended. This case illustrates why evaluation of SNR is first needed to determine if the DPOAE levels can be properly interpreted. Case Study 2 • Infant number 2 had no risk factors for HL and was diagnosed with an MHL via ABR with air conduction thresholds of 70 dB nHL at 1 and 4 kHz with a 30 dB air-bone gap at 1 kHz. Ambient absorbance was extremely low from 0.25 to 8 kHz ( Figure 7A ). DPOAE responses displayed in Figure 7B show a very high DPOAE level (48.0 dB SPL) and SNR (40.5 dB) at 3 kHz which could be an example of a system malfunction, whether due to probe distortion or some other artifact. It is unlikely due to spontaneous OAEs, as ABR thresholds were 70 dB nHL at 1 and 4 kHz. When DPOAE level and SNR symmetry cutoff criteria were used to determine overall DPOAE status, infant number 2 only passed DPOAE level at 3 and 4 kHz and passed DPOAE SNR at 3 and 5.5 kHz. In the multifrequency analysis, infant number 2 only passed both DPOAE level and SNR criteria at 3 kHz; therefore, DPOAE responses did not meet the 3 of 5 criteria and were correctly identified as consistent with abnormal OHC function. If abnormally high DPOAE responses are observed during testing, it is recommended that DPOAE testing be repeated to confirm results. -8 kHz) . The light gray shaded region represents normative range based on the model mean estimated 95% confidence intervals obtained from normal infants (Hunter et al. 2016) . B, DPOAE level and SNR values obtained at the same study visit. The gray shaded region represents the area of overlap between the distributions of the 90th percentile from infants with hearing loss and the 10th percentile obtained from normal-hearing infants at approximately 1 month of age. DPOAE level and SNRs that are above the symmetry cutoff values (dotted line) are consistent with normal outer hair cell function and those plotted below are consistent with abnormal function. In addition, overall DPOAE level can be further categorized as normal (N), low (L), or absent or abnormal (A). DPOAE indicates distortion product otoacoustic emission; HL, hearing loss; NH, normal hearing; SNR, signal to noise ratio.
Case Study 3 • Infant number 3 had no risk factors for HL. ABR air conduction thresholds were 60 dB nHL at 0.5, 1, 2, and 4 kHz with a 10 dB air-bone gap at 4 kHz. MHL was confirmed with VRA in a clinical audiological evaluation around 9 to 12 months of age. Ambient absorbance was low from 0.25 to 1 and within normal limits from 1 to 8 kHz (Fig. 8A) . DPOAE responses displayed in Figure 8B show a DPOAE level and SNR at 5.5 kHz of 10.2 dB SPL and 27.2 dB respectively, which were well above the symmetry cutoff values of 2.5 and 10.6 dB, respectively. In addition, the DPOAE level at 4 kHz was 5.94 dB, which barely exceeded the symmetry cutoff point of 5.9 dB. Using multifrequency rules, infant number 3 passed both DPOAE level and SNR at 4.0 and 5.5 kHz, but did not pass at all other frequencies (2, 3, and 8 kHz). This case study highlights the importance of requiring the majority of test frequencies (3 out of 4, or 3 out of 5 frequencies) to pass both DPOAE level and SNR. If a criterion of 2 out of 4 frequencies was implemented, this infant with a 60 dB nHL MHL would be incorrectly classified as normal.
The aforementioned cases highlight the importance of using both DPOAE level and SNR and using multifrequency rules when interpreting DPOAE responses for an overall judgment of DPOAE responses. The present study is in agreement with recommendations that SNR levels be evaluated first to determine if the response is interpretable, then to interpret DPOAE level to evaluate the presence/absence of the response. Had only level been used, these infants may have been incorrectly classified as normal at some frequencies.
Limitations and Future Directions
There are several limitations in the present study. Although infants who did not pass their newborn hearing screening at the birth hospital were preferentially enrolled, the majority of infants included in the study had NH. Therefore, the prediction of HL analyses was based on a relatively small number of infants with HL, with the majority having a CHL. Replication in studies that include more infants with various types (CHL, SNHL, and MHL) and degrees of HL would be desirable. Increasing the sample size would also allow for a cost analysis (false positive and false negative) to be completed. The present study analyzed only the wideband absorbance test at ambient pressure in the ear canal. A future direction would be to compare the ambient absorbance test with a wideband tympanometric absorbance test at varying air pressures in the ear canal, which may provide additional information of diagnostic relevance. Last, although more precise ABR threshold testing is desirable, it would significantly increase the overall test time.
CONCLUSIONS
Hearing impairment is one of the most common disabilities reported in infants. Early identification of HL combined with immediate age-appropriate intervention is essential for optimal speech and language development. DPOAEs are a commonly used diagnostic tool to evaluate cochlear function; however, to maximize test performance, age-appropriate normative data are essential. This is the first study to report DPOAE level and SNR symmetry cutoff values that can be used to evaluate the presence of HL from birth to 4 months of age. Inasmuch as the AUC values from 1 to 1.5 kHz were poorer, the 2 to 8 kHz range is recommended for the most accurate prediction of HL and DPOAE test performance is improved by including higher F 2 test frequencies. A multifrequency criterion of 3 out of 4 frequencies for the "4 Frequency Analysis (3, 4, 5.5, and 8 kHz)" or 3 out of 5 frequencies for the "5 Frequency Analysis (2, 3, 4, 5.5, and 8 kHz)" passing both SNR and DPOAE level at or above the symmetry cutoff values is recommended for clinical interpretation of DPOAEs in infants. DPOAEs may be used to help determine the presence of mild and greater degrees of HL; however, absorbance measures would be helpful to verify type of HL. In addition, threshold tests such as the ABR or a behavioral audiogram is necessary to confirm the degree, type, and configuration of HL to guide rehabilitation plans. Figure 6 for a detailed description of shaded regions and symmetry cutoff values. DPOAE indicates distortion product otoacoustic emission; HL, hearing loss; NH, normal hearing; SNR, signal to noise ratio.
